New Delhi: Aakash Healthcare on Tuesday said its vaccination volumes have risen by nearly 72 per cent in the post-COVID period, with a sharp increase in adult immunisation driven by heightened awareness around preventive healthcare.
The hospital released an analysis of its vaccination data from FY2017–18 to FY2025–26, which showed a sustained rise in uptake across both paediatric and adult populations.
According to the data, Aakash Healthcare administered a cumulative 1,23,941 vaccine doses over the nine-year period. Vaccination volumes peaked in FY2024–25 at 18,188 doses, reflecting growing public awareness about timely immunisation.
The analysis showed that average annual vaccination volumes increased from 9,902 doses in the pre-COVID period (FY17–FY20) to 17,011 doses in the post-COVID period (FY22–FY26), marking a 71.8 per cent rise.
“The COVID-19 pandemic fundamentally changed how people view preventive healthcare. Our data shows adults are now far more proactive about protecting themselves against preventable diseases,” Aakash Healthcare Managing Director Dr Aashish Chaudhry said.
He added that vaccines traditionally associated with childhood immunisation, such as influenza, pneumococcal and hepatitis, are increasingly being adopted by adults.
“Adult immunisation is a critical yet often overlooked pillar of public health. Increasing awareness about life-course immunisation will be key to reducing disease burden and strengthening community health,” he said.
The report highlighted a significant rise in adult vaccination demand post-pandemic, particularly for influenza, pneumococcal, hepatitis B, typhoid and HPV vaccines.
Average annual adult vaccine doses rose 63.3 per cent, from 3,390 in the pre-COVID period to 5,535 in the post-COVID years. Adult vaccinations accounted for 37 per cent of total doses in the latest fiscal year.
Doctors noted that adult vaccination plays a key role in reducing hospitalisations, long-term complications and the spread of infectious diseases.
Paediatric immunisation continued to account for the majority share, contributing 63 per cent of total vaccination volumes in the latest fiscal year.
Average annual paediatric doses increased 76.4 per cent, from 6,457 in the pre-COVID period to 11,391 in the post-COVID years, as parents prioritised routine immunisation schedules.
Commonly administered vaccines included those for pneumococcal infections, tuberculosis (BCG), influenza, tetanus, hepatitis B, rotavirus and MMR.
Experts said the findings reflect a broader shift towards preventive healthcare, with vaccination increasingly being seen as a lifelong health practice rather than limited to childhood.
They added that maintaining updated immunisation schedules for both children and adults is crucial for preventing disease outbreaks, reducing hospitalisations and strengthening community immunity.
